123 related articles for article (PubMed ID: 36669241)
1. Generation of two mother-child pairs of iPSCs from maternally inherited Leigh syndrome patients with m.8993 T > G and m.9176 T > G MT-ATP6 mutations.
Henke MT; Zink A; Diecke S; Prigione A; Schuelke M
Stem Cell Res; 2023 Mar; 67():103030. PubMed ID: 36669241
[TBL] [Abstract][Full Text] [Related]
2. Generation of four iPSC lines from four patients with Leigh syndrome carrying homoplasmic mutations m.8993T > G or m.8993T > C in the mitochondrial gene MT-ATP6.
Lorenz C; Zink A; Henke MT; Staege S; Mlody B; Bünning M; Wanker E; Diecke S; Schuelke M; Prigione A
Stem Cell Res; 2022 May; 61():102742. PubMed ID: 35279592
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.
Uittenbogaard M; Brantner CA; Fang Z; Wong LC; Gropman A; Chiaramello A
Mol Genet Metab; 2018 May; 124(1):71-81. PubMed ID: 29602698
[TBL] [Abstract][Full Text] [Related]
4. RNA-based generation of iPSCs from a boy carrying the mutation m.9185 T>C in the mitochondrial gene MT-ATP6 and from his healthy mother.
Steiner T; Zink A; Henke MT; Cecchetto G; Buenning M; Rossi A; Schuelke M; Prigione A
Stem Cell Res; 2022 Oct; 64():102920. PubMed ID: 36137325
[TBL] [Abstract][Full Text] [Related]
5. Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy.
Licchetta L; Ferri L; La Morgia C; Zenesini C; Caporali L; Lucia Valentino M; Minardi R; Fulitano D; Di Vito L; Mostacci B; Alvisi L; Avoni P; Liguori R; Tinuper P; Bisulli F; Carelli V
Ann Clin Transl Neurol; 2021 Mar; 8(3):704-710. PubMed ID: 33476484
[TBL] [Abstract][Full Text] [Related]
6. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human iPSC line from a patient with Leigh syndrome caused by a mutation in the MT-ATP6 gene.
Galera-Monge T; Zurita-Díaz F; González-Páramos C; Moreno-Izquierdo A; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 May; 16(3):766-9. PubMed ID: 27346203
[No Abstract] [Full Text] [Related]
8. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
9. Leigh syndrome T8993C mitochondrial DNA mutation: Heteroplasmy and the first clinical presentation in a Vietnamese family.
Weerasinghe CAL; Bui BT; Vu TT; Nguyen HT; Phung BK; Nguyen VM; Pham VA; Cao VH; Phan TN
Mol Med Rep; 2018 May; 17(5):6919-6925. PubMed ID: 29512743
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome C oxydase deficiency: SURF1 gene investigation in patients with Leigh syndrome.
Maalej M; Kammoun T; Alila-Fersi O; Kharrat M; Ammar M; Felhi R; Mkaouar-Rebai E; Keskes L; Hachicha M; Fakhfakh F
Biochem Biophys Res Commun; 2018 Mar; 497(4):1043-1048. PubMed ID: 29481804
[TBL] [Abstract][Full Text] [Related]
11. A point mutation of mitochondrial ATPase 6 gene in Leigh syndrome.
Akagi M; Inui K; Tsukamoto H; Sakai N; Muramatsu T; Yamada M; Matsuzaki K; Goto Y; Nonaka I; Okada S
Neuromuscul Disord; 2002 Jan; 12(1):53-5. PubMed ID: 11731285
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.
D'Aurelio M; Vives-Bauza C; Davidson MM; Manfredi G
Hum Mol Genet; 2010 Jan; 19(2):374-86. PubMed ID: 19875463
[TBL] [Abstract][Full Text] [Related]
13. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome.
Na JH; Lee YM
Acta Neurol Scand; 2022 Apr; 145(4):414-422. PubMed ID: 34877647
[TBL] [Abstract][Full Text] [Related]
15. Maternally inherited Leigh syndrome: T8993G mutation in a Tunisian family.
Mkaouar-Rebai E; Chaari W; Younes S; Bousoffara R; Sfar MT; Fakhfakh F
Pediatr Neurol; 2009 Jun; 40(6):437-42. PubMed ID: 19433277
[TBL] [Abstract][Full Text] [Related]
16. Is the variant m.9176T > C in MT-ATP6 truly responsibly for Leigh syndrome?
Finsterer J
Pediatr Int; 2020 Oct; 62(10):1217. PubMed ID: 32686207
[No Abstract] [Full Text] [Related]
17. Generation of a human iPSC line from a patient with Leigh syndrome.
Galera T; Zurita F; González-Páramos C; Moreno-Izquierdo A; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):63-6. PubMed ID: 27345786
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line (IUFi002-A) from a Leigh syndrome patient carrying mutations in the NDUFS1 gene.
Valente O; Dobner J; Ramachandran H; Hildebrandt B; Distelmaier F; Ventura N; Rossi A
Stem Cell Res; 2022 Dec; 65():102971. PubMed ID: 36403546
[TBL] [Abstract][Full Text] [Related]
19. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient.
Guo X; Ji W; Niu C; Ding Y; Chen Z; Chen C; Tong H; Han Z; Chu M
Stem Cell Res; 2020 Dec; 49():102085. PubMed ID: 33202306
[TBL] [Abstract][Full Text] [Related]
20. Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism.
Kenvin S; Torregrosa-Muñumer R; Reidelbach M; Pennonen J; Turkia JJ; Rannila E; Kvist J; Sainio MT; Huber N; Herukka SK; Haapasalo A; Auranen M; Trokovic R; Sharma V; Ylikallio E; Tyynismaa H
Hum Mol Genet; 2022 Mar; 31(6):958-974. PubMed ID: 34635923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
